Trials / Completed
CompletedNCT01970111
An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the long-term safety, efficacy, and pharmacokinetics of KPS-0373 in SCD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KPS-0373, High dose | |
| DRUG | KPS-0373, Low dose |
Timeline
- Primary completion
- 2015-07-01
- First posted
- 2013-10-25
- Last updated
- 2016-04-18
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01970111. Inclusion in this directory is not an endorsement.